Recent Company News

• 04:53 AM ET Apr 22, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:37 PM ET Apr 28, 2025
  

  Cellectis presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting (€1.43, 0.00)

• 12:06 PM ET Apr 10, 2025
  

  Cellectis SA initiated outperform at Oddo (€1.17, 0.00)

• 05:55 AM ET Apr 04, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (337 total)

• 04:58 AM ET Mar 17, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (110 total)

• 09:16 AM ET Mar 14, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:53 AM ET Mar 14, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:31 AM ET Mar 14, 2025
  

  StreetAccount Summary - US Pre-market trading

• 06:21 PM ET Mar 13, 2025
  

  Cellectis SA reports Q4 EPS ($0.17) vs FactSet ($0.18) [6 est, ($0.37)-0.06] (€1.25, 0.00)